Helen S. Te

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

Paul Y. Kwo, Parvez Mantry, Eoin Coakley et al. · New England Journal of Medicine · 2014 · 402 citations · Full text

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States

Michael H. Le, Pardha Devaki, Nghiem B. Ha et al. · PLoS ONE · 2017 · 285 citations · Full text

Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events

Lisa B. VanWagner, Manali Bhave, Helen S. Te et al. · Hepatology · 2012 · 220 citations

Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease

Helen S. Te, Thomas D. Schiano, Shih Fan Kuan et al. · The American Journal of Gastroenterology · 2000 · 153 citations

Hepatic Effects, Immunology, Gastroenterology +17